X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-11-05 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $40.00 | -6,466 | 82,973 | -7% | -$258,640 | ||||||
| D | 2025-11-05 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $45.06 | -43,196 | 30,468 | -59% | -$1,946,288 | |||||
2025-11-05 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $40.02 | -9,674 | 13,554 | -42% | -$387,191 | ||||||
2025-11-05 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $41.00 | -7,000 | 126,158 | -5% | -$287,000 | ||||||
2025-11-04 | EXAS | Exact Sciences Corp | Herriott James | SVP, GC, Sec | S - Sale | $70.08 | -1,500 | 14,141 | -10% | -$105,120 | ||||||
2025-11-04 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM, Precision Oncology | S - Sale | $70.08 | -2,858 | 23,038 | -11% | -$200,289 | ||||||
2025-11-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.04 | -221 | 58,032 | 0% | -$672 | ||||||
| M | 2025-11-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.84 | -9,373 | 314,987 | -3% | -$289,079 | |||||
2025-11-03 | PSNL | Personalis, Inc. | Hall Christopher M | Pres, CEO | S - Sale | $8.99 | -29,612 | 148,486 | -17% | -$266,212 | ||||||
2025-11-04 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $200.51 | -22,900 | 2,285,852 | -1% | -$4,591,674 | ||||||
2025-11-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $200.07 | -4,000 | 287,794 | -1% | -$800,274 | ||||||
2025-11-03 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $198.60 | -3,000 | 112,061 | -3% | -$595,810 | ||||||
2025-11-03 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $198.71 | -122 | 5,762 | -2% | -$24,243 | ||||||
2025-10-31 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $25.04 | -12,678 | 128,506 | -9% | -$317,457 | ||||||
| A | 2025-08-27 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $21.69 | -18,007 | 153,861 | -10% | -$390,572 | |||||
2025-11-04 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.07 | -2,000 | 95,932 | -2% | -$6,140 | ||||||
2025-10-31 | LH | Labcorp Holdings Inc. | Parham Richelle P | Dir | S - Sale | $254.28 | -7,009 | 2,469 | -74% | -$1,782,273 | ||||||
| D | 2025-11-03 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $199.96 | -160,703 | 144,816 | -53% | -$32,133,981 | |||||
2025-11-03 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $200.00 | -17,100 | 2,308,752 | -1% | -$3,420,003 | ||||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $191.80 | -6,015 | 149,840 | -4% | -$1,153,656 | |||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $191.15 | -5,063 | 64,126 | -7% | -$967,778 | |||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $191.98 | -479 | 291,794 | 0% | -$91,959 | |||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $191.87 | -1,993 | 201,699 | -1% | -$382,390 | |||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $191.86 | -2,206 | 115,061 | -2% | -$423,234 | |||||
| M | 2025-10-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $191.86 | -1,709 | 150,699 | -1% | -$327,882 | |||||
2025-10-24 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale | $65.00 | -12,000 | 60,759 | -16% | -$780,000 | ||||||
| DM | 2025-10-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $190.30 | -2,170 | 69,189 | -3% | -$412,951 | |||||
| D | 2025-10-22 | DGX | Quest Diagnostics Inc | Pfeiffer Gary M | Dir | S - Sale+OE | $182.40 | -1,482 | 29,431 | -5% | -$270,317 | |||||
2025-10-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $22.44 | -1,339 | 324,360 | 0% | -$30,047 | ||||||
2025-10-20 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $190.00 | -10,000 | 2,325,852 | 0% | -$1,900,000 | ||||||
| D | 2025-10-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $187.95 | -93 | 292,273 | 0% | -$17,479 | |||||
| D | 2025-10-21 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $187.95 | -464 | 203,692 | 0% | -$87,209 | |||||
2025-10-21 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $187.95 | -292 | 117,267 | 0% | -$54,881 | ||||||
2025-10-21 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $187.95 | -339 | 152,408 | 0% | -$63,715 | ||||||
| D | 2025-10-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $187.95 | -1,603 | 155,855 | -1% | -$301,284 | |||||
| D | 2025-10-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $187.95 | -602 | 70,109 | -1% | -$113,146 | |||||
2025-10-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $66.95 | -116 | 7,725 | -1% | -$7,766 | ||||||
2025-10-17 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $66.95 | -26 | 18,324 | 0% | -$1,741 | ||||||
2025-10-16 | XGN | Exagen Inc. | Aballi John | Pres, CEO | S - Sale | $11.82 | -31,787 | 754,828 | -4% | -$375,598 | ||||||
| M | 2025-10-15 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $176.60 | -4,570 | 292,176 | -2% | -$807,042 | |||||
2025-10-15 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $68.88 | -7,239 | 727,388 | -1% | -$498,622 | ||||||
| M | 2025-10-15 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $78.47 | -14,979 | 381,818 | -4% | -$1,175,394 | |||||
2025-10-09 | EXAS | Exact Sciences Corp | Herriott James | SVP, GC, Sec | S - Sale | $60.00 | -1,500 | 15,641 | -9% | -$90,000 | ||||||
2025-10-09 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $60.00 | -2,000 | 57,962 | -3% | -$120,000 | ||||||
2025-10-07 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.18 | -2,000 | 97,932 | -2% | -$6,360 | ||||||
2025-10-06 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $62.50 | -81,385 | 396,797 | -17% | -$5,086,563 | ||||||
2025-10-06 | VCYT | Veracyte, Inc. | Febbo Phillip G. | Chief Scientific, Med Officer | S - Sale | $36.02 | -8,349 | 92,441 | -8% | -$300,709 | ||||||
2025-10-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.16 | -227 | 58,253 | 0% | -$717 | ||||||
2025-10-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $22.58 | -1,339 | 325,699 | 0% | -$30,235 | ||||||
2025-10-02 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $64.00 | -9,692 | 478,182 | -2% | -$620,312 | ||||||
2025-10-01 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $35.00 | -2,539 | 89,099 | -3% | -$88,865 | ||||||
| D | 2025-10-01 | VCYT | Veracyte, Inc. | Epstein Robert S | Dir | S - Sale+OE | $35.08 | -21,473 | 62,446 | -26% | -$753,204 | |||||
2025-10-01 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $35.00 | -2,160 | 89,439 | -2% | -$75,608 | ||||||
2025-10-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.99 | -3,000 | 117,559 | -2% | -$479,969 | ||||||
| D | 2025-09-30 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $162.05 | -1,364 | 203,300 | -1% | -$221,040 | |||||
| DM | 2025-09-30 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $160.80 | -23,192 | 154,072 | -13% | -$3,729,372 | |||||
| D | 2025-09-30 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $162.05 | -2,491 | 69,189 | -3% | -$403,674 | |||||
| D | 2025-09-26 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $188.13 | -227 | 43,809 | -1% | -$42,706 | |||||
| DM | 2025-09-23 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $187.12 | -28,463 | 43,808 | -39% | -$5,326,042 | |||||
2025-09-19 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $33.69 | -2,283 | 91,599 | -2% | -$76,920 | ||||||
2025-09-19 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $7.04 | +142,045 | 2,130,745 | +7% | +$999,997 | ||||||
| M | 2025-09-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $178.70 | -14,070 | 296,746 | -5% | -$2,514,354 | |||||
| M | 2025-09-18 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $180.33 | -50,000 | 2,335,852 | -2% | -$9,016,668 | |||||
2025-09-17 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.97 | -1,339 | 327,038 | 0% | -$29,419 | ||||||
| M | 2025-09-17 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $6.06 | +18,373 | 1,988,700 | +1% | +$111,425 | |||||
2025-09-16 | RDNT | Radnet, Inc. | Stolper Mark | EVP, CFO | S - Sale | $73.89 | -35,000 | 68,012 | -34% | -$2,586,150 | ||||||
| D | 2025-09-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $55.63 | -116 | 7,591 | -2% | -$6,453 | |||||
| D | 2025-09-17 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale+OE | $55.63 | -26 | 18,281 | 0% | -$1,446 | |||||
| D | 2025-09-16 | FTRE | Fortrea Holdings Inc. | Parks Robert | Chief Accounting Officer | S - Sale+OE | $9.95 | -7,338 | 19,046 | -28% | -$73,013 | |||||
2025-09-16 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $74.44 | -14,000 | 68,181 | -17% | -$1,042,160 | ||||||
2025-09-12 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $170.54 | -5,000 | 2,385,852 | 0% | -$852,707 | ||||||
2025-09-12 | GH | Guardant Health, Inc. | Hidalgo Medina Manuel | Dir | S - Sale | $54.16 | -2,165 | 851 | -72% | -$117,251 | ||||||
2025-09-11 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $72.13 | -500 | 53,495 | -1% | -$36,065 | ||||||
2025-09-10 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $72.74 | -10,000 | 239,183 | -4% | -$727,400 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.13 | -3,246 | 807,890 | 0% | -$10,160 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $3.13 | -1,271 | 175,669 | -1% | -$3,978 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $3.13 | -934 | 126,817 | -1% | -$2,923 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.13 | -645 | 99,932 | -1% | -$2,019 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $3.13 | -1,395 | 159,493 | -1% | -$4,366 | ||||||
2025-09-11 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.13 | -915 | 284,670 | 0% | -$2,864 | ||||||
2025-09-09 | GH | Guardant Health, Inc. | Eltoukhy Helmy | Co-CEO | S - Sale | $59.45 | -300,000 | 2,123,499 | -12% | -$17,835,995 | ||||||
| A | 2025-09-09 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -1,560 | 21,153 | -7% | -$4,758 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Parks Robert | Chief Accounting Officer | S - Sale+OE | $10.23 | -592 | 1,450 | -29% | -$6,056 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | S - Sale+OE | $10.23 | -1,677 | 19,092 | -8% | -$17,156 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $10.23 | -3,155 | 61,601 | -5% | -$32,276 | |||||
| D | 2025-09-09 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $10.23 | -3,156 | 58,770 | -5% | -$32,286 | |||||
2025-09-09 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $71.99 | -500 | 53,995 | -1% | -$35,995 | ||||||
2025-09-08 | CELC | Celcuity Inc. | Baker Bros. Advisors LP | 10% | P - Purchase | $56.27 | +170,100 | 7,211,484 | +2% | +$9,571,319 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $3.15 | -21,158 | 811,136 | -3% | -$66,648 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $3.15 | -5,263 | 285,585 | -2% | -$16,578 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Lawrence Sandra Aj | Dir | S - Sale | $3.05 | -3,899 | 18,814 | -17% | -$11,892 | ||||||
2025-09-09 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.05 | -2,000 | 100,577 | -2% | -$6,100 | ||||||
2025-09-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $30.41 | -7,667 | 334,185 | -2% | -$233,133 | ||||||
2025-09-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $166.53 | -5,079 | 158,514 | -3% | -$845,795 | ||||||
2025-09-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.62 | -3,000 | 120,859 | -2% | -$499,865 | ||||||
2025-09-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.35 | -222 | 58,480 | 0% | -$744 | ||||||
2025-09-02 | XGN | Exagen Inc. | Black Jeffrey G. | CFO | S - Sale | $9.79 | -20,466 | 269,026 | -7% | -$200,362 | ||||||
2025-09-02 | FTRE | Fortrea Holdings Inc. | Russell Erin L | Dir | P - Purchase | $10.15 | +9,854 | 9,854 | New | +$100,018 | ||||||
2025-09-02 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $23.93 | -1,339 | 328,377 | 0% | -$32,042 | ||||||
2025-09-02 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $65.84 | -100 | 11,183 | -1% | -$6,584 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |